Nathan R. Wiblin
- Co-authors
- Debbie J. HarrisRoger HewsonSusan FotheringhamKathryn A. RyanFrancisco J. SalgueroKaren E. GoochOliver DibbenStuart Dowall
- Topics
- Antibiotics Pharmacokinetics and Efficacy (1 paper)SARS-CoV-2 and COVID-19 Research (1 paper)Influenza Virus Research Studies (1 paper)
- Journals
- PLoS ONEVirusesnpj Vaccines
- Partner nations
- United Kingdom
In The Last Decade
Nathan R. Wiblin
3 papers receiving 18 citations
Peers
Comparison fields: 5 of 19
- Infectious Diseases 12
- Epidemiology 10
- Molecular Biology 4
- Pulmonary and Respiratory Medicine 3
- Immunology 3
Countries citing papers authored by Nathan R. Wiblin
This map shows the geographic impact of Nathan R. Wiblin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan R. Wiblin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan R. Wiblin more than expected).
Fields of papers citing papers by Nathan R. Wiblin
This network shows the impact of papers produced by Nathan R. Wiblin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan R. Wiblin. The network helps show where Nathan R. Wiblin may publish in the future.
Co-authorship network of co-authors of Nathan R. Wiblin
This figure shows the co-authorship network connecting the top 25 collaborators of Nathan R. Wiblin. A scholar is included among the top collaborators of Nathan R. Wiblin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan R. Wiblin. Nathan R. Wiblin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 3 | |
| 3 | 11 |
About Nathan R. Wiblin
Nathan R. Wiblin is a scholar working on Modeling and Simulation, Psychiatry and Mental health and Pharmacology, having authored 3 papers that have together received 20 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Influenza Virus Research Studies (1 paper). The work is most often cited by research in Infectious Diseases (12 citations), Epidemiology (10 citations) and Modeling and Simulation (1 citation). Nathan R. Wiblin has collaborated with scholars based in United Kingdom. Frequent co-authors include Debbie J. Harris, Roger Hewson, Susan Fotheringham, Kathryn A. Ryan, Francisco J. Salguero, Karen E. Gooch, Oliver Dibben, Stuart Dowall, Graham Hatch and Oliver Carnell. Their work appears in journals such as PLoS ONE, Viruses and npj Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.